Takeda Pharmaceutical
309 hedge funds and large institutions have $1.9B invested in Takeda Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 89 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.26% less ownership
Funds ownership: 7.08% → 6.82% (-0.26%)
4% less capital invested
Capital invested by funds: $1.98B → $1.9B (-$78.4M)
14% less call options, than puts
Call options by funds: $54M | Put options by funds: $63.1M
Holders
309
Holding in Top 10
7
Calls
$54M
Puts
$63.1M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$11.8M | |
| 3 | +$10.6M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$7.66M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.29M |
Top Sellers
| 1 | -$25M | |
| 2 | -$18M | |
| 3 | -$16.1M | |
| 4 |
AC
Adelphi Capital
London,
United Kingdom
|
-$15.7M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$13M |